ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

20,919Medicare Part D Prescriptions Filled, Including Refills

Rank: 8 out of 434

$836K Total Retail Price of All Prescriptions

Rank: 8 out of 434

1,249 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
18% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nevada
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 1,249 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

13% of this provider’s 1,249 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 19,068 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$40 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 13.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nevada
LISINOPRIL 1,018 907 1 1
SIMVASTATIN 892 831 2 2
AMLODIPINE BESYLATE 859 833 3 6
LEVOTHYROXINE SODIUM 857 760 4 3
OMEPRAZOLE 821 745 5 5
PRAVASTATIN SODIUM 667 615 6 17
HYDROCODONE-ACETAMINOPHEN 606 468 S3 7 4
LOSARTAN POTASSIUM 518 503 8 13
HYDROCHLOROTHIAZIDE 411 375 9 8
METFORMIN HCL 399 373 10 7
FUROSEMIDE 394 369 11 9
WARFARIN SODIUM 390 367 12 18
ZOLPIDEM TARTRATE 382 355 13 11
ALENDRONATE SODIUM 360 349 14 15
METOPROLOL SUCCINATE 328 292 15 22
CARVEDILOL 316 291 16 24
GABAPENTIN 300 249 17 14
ALLOPURINOL 291 261 18 25
ATENOLOL 291 266 18 16
LOVASTATIN 270 256 20 10
GEMFIBROZIL 265 238 21 62
METOPROLOL TARTRATE 258 245 22 12
FENOFIBRATE 244 223 23 43
LISINOPRIL-HYDROCHLOROTHIAZIDE 225 194 24 21
VENTOLIN HFA 225 204 24 30
TERAZOSIN HCL 221 218 26 40
FLUOXETINE HCL 215 188 27 32
CITALOPRAM HBR 197 172 28 23
PEN NEEDLE 182 177 29 83
GLIPIZIDE ER 173 171 30 65
LOSARTAN-HYDROCHLOROTHIAZIDE 170 159 31 39
TRAZODONE HCL 170 130 31 33
FLUTICASONE PROPIONATE 167 136 33 26
DONEPEZIL HCL 158 158 34 35
CLOPIDOGREL 151 145 35 41
TRAMADOL HCL 146 130 36 28
SPIRIVA 143 141 37 36
METFORMIN HCL ER 139 114 38 48
CLONIDINE HCL 139 128 38 63
POTASSIUM CHLORIDE 138 135 40 20
KLOR-CON 10 133 117 41 116
GLIPIZIDE 130 122 42 37
PLAVIX 127 118 43 64
GLYBURIDE 126 119 R 44 51
PREDNISONE 122 115 45 42
LEVEMIR FLEXPEN 120 120 46 139
PAROXETINE HCL 118 102 47 61
ATORVASTATIN CALCIUM 116 114 48 19
BENAZEPRIL HCL 116 113 48 49
NIASPAN 112 100 50 145
FINASTERIDE 110 98 51 54
RANITIDINE HCL 108 100 52 31
AZITHROMYCIN 107 100 53 38
SERTRALINE HCL 105 89 54 27
AMITRIPTYLINE HCL 95 80 R 55 57
DIGOXIN 92 92 56 69
HUMALOG 91 87 57 188
ISOSORBIDE MONONITRATE ER 91 80 57 68
NAMENDA 86 74 59 72
OXYBUTYNIN CHLORIDE 85 73 60 82
SPIRONOLACTONE 81 72 61 70
IBUPROFEN 78 65 62 56
FAMOTIDINE 78 75 62 76
SYMBICORT 78 70 62 93
VENLAFAXINE HCL 77 67 65 173
LANTUS SOLOSTAR 73 69 66 71
CIPROFLOXACIN HCL 72 62 67 55
BENICAR 72 72 67 121
ACYCLOVIR 67 57 69 125
TRIAMTERENE-HCTZ 66 60 70 47
DOXYCYCLINE HYCLATE 65 57 71 122
ENALAPRIL MALEATE 65 56 71 59
DILTIAZEM HCL 62 53 73 260
MORPHINE SULFATE ER 60 44 S2 74 50
QVAR 59 51 75 90
VERAPAMIL ER 56 56 76 78
EVISTA 55 55 77 132
ROPINIROLE HCL 55 46 77 104
PROPRANOLOL HCL 54 51 79 102
ADVAIR DISKUS 54 54 79 52
BENICAR HCT 54 54 79 155
VYTORIN 54 54 79 169
KLOR-CON M10 50 50 83 219
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 17, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.